Edwin Kwok & Co (“EKC“) is pleased to announce that recently it has successful represented a leading health technology company in its strategic acquisition of all shares in a premium wellness brand with stores across Hong Kong, Singapore, and Macau. The purchaser is a prominent player in the global health technology sector with operations spanning Asia, Europe, and North America, dedicated to transforming lives through innovative wellness solutions.
The target company is a respected leader in the premium wellness and therapeutic products industry, with a strong market presence across multiple Asian markets. The company has built a distinguished reputation for its comprehensive range of relaxation, fitness, diagnostic, and therapeutic products, maintaining strategic partnerships with established manufacturers and positioning itself as a trusted wellness brand in the region.
This cross-border transaction involved the acquisition of operating companies in three key Asian jurisdictions, requiring sophisticated coordination of Hong Kong, Singapore, and Macau legal frameworks. The deal represents a significant strategic expansion for the purchaser in the premium wellness sector and demonstrates the continued consolidation within the health technology industry.
EKC served as lead international counsel for the purchaser throughout the entire transaction. The transaction showcases our firm’s exceptional capability in handling complex cross-border M&A transactions and our deep understanding of Asian market dynamics.
The EKC team was led by Edwin Kwok and Iris Leung, and includes our consultants Lillian Cheung and Yuki Tsang, as well as our associates Mingkun Ding and Grace Hua.
Edwin Kwok & Co focuses on a full range of corporate, capital markets, mergers and acquisitions, private equity, and regulatory matters. With combined U.S., Hong Kong and English law capabilities, we provide integrated, comprehensive and innovative solutions on a wide variety of matters globally.
Contact:
Edwin Kwok & Co
